Against the backdrop of accelerating innovation in the high-end medical device industry and the growing emphasis on domestic development of critical components, Zhejiang Jiacheng Medical Instrument Co., Ltd. remains committed to technological innovation, specializing in the R&D and manufacturing of precision optical components for rigid endoscopes. The company focuses on key technical challenges in the industry and continuously advances core manufacturing process development, technological achievement transformation, and industrial application.
Recognizing its technological innovation in the bonding process for medical endoscope light-guide fibers, the company's related project was selected as an Outstanding Scientific and Technological Innovation Achievement (Case) at the 24th Scientists Forum. The company was also recognized as a Technology Innovation and New Quality Enterprise. Meanwhile, the company's founder, Huangfulijun, participated in several high-level scientific and technological exchange events, including the 24th Scientists Forum and the 9th Enterprise Chief Scientist Forum, engaging with experts, scholars, and industry representatives to explore technological innovation, achievement commercialization, and the development of an independently controlled industrial supply chain for high-end medical devices.
I. Core Technological Innovation: Overcoming Manufacturing Challenges
Rigid endoscopes are important medical devices used in minimally invasive procedures, particularly in urology. Their performance, operational stability, and service life are closely related to the manufacturing processes and quality control of their core optical components.
Among these components, the light-guide fiber assembly plays a vital role in transmitting illumination within the endoscope. In clinical applications, rigid endoscopes must undergo repeated sterilization processes, including high-temperature and high-pressure sterilization as well as hydrogen peroxide low-temperature plasma sterilization. These repeated sterilization cycles place demanding requirements on the bonding strength, temperature resistance, and structural stability of fiber-bonding interfaces.Conventional bonding processes may experience reduced bonding strength, material aging, fiber detachment, water ingress, and corrosion after prolonged use, potentially affecting equipment performance and service life.
To address these industry challenges, Huangfulijun, founder of Jiacheng Medical, has devoted years to the R&D and manufacturing of precision optical components for rigid endoscopes. As a key inventor, he led the development of the invention patent "Bonding Process for Medical Endoscope Light-Guide Fibers" (Patent No. ZL 2022 1 1614183.7).
The patented technology focuses on innovations in the bonding process between endoscope light-guide fibers and the endoscope body. By optimizing key parameters and procedures, including bonding materials, process temperatures, adhesive penetration, and staged curing, the technology improves the bonding strength and quality between optical fibers and the endoscope body while reducing the risk of damage caused by repeated sterilization and complex operating environments.This technology helps address issues such as debonding, water ingress, and corrosion under repeated high-temperature, high-pressure, and hydrogen peroxide plasma sterilization conditions. It also enhances the temperature resistance, impact resistance, and corrosion resistance of fiber assemblies, providing technical support for extending the overall service life of rigid endoscopes.
This achievement demonstrates the company's independent R&D capabilities in precision optical component manufacturing and provides additional technological support for the localization of critical optical components used in minimally invasive rigid endoscopes, including ureteroscopes and nephroscopes.
II. Patent Recognition: Demonstrating Innovation Strength
Based on the patented technology and related industrialization achievements, Zhejiang Jiacheng Medical Instrument Co., Ltd. and its founder Huangfulijun were recognized in connection with the Outstanding Scientific and Technological Innovation Achievement (Case) at the 24th Scientists Forum.The company received the recognition of Technology Innovation and New Quality Enterprise, while the relevant patented technological achievement was also included among the forum's outstanding scientific and technological innovation cases.
For Jiacheng Medical, this recognition represents not only an honor but also encouragement for its continued commitment to independent R&D, specialized technological development, and the commercialization of innovation achievements.The company will continue to focus on the technological requirements of rigid endoscope core components, with ongoing investment in precision optical manufacturing, key process optimization, and product performance enhancement. Through these efforts, Jiacheng Medical aims to strengthen its independent innovation capabilities and advance the manufacturing of critical components toward higher precision, greater stability, and improved reliability.
III. Participation in the Scientists Forum: Promoting Technology Commercialization
In November 2024, Huangfulijun, founder of Jiacheng Medical, traveled to Beijing to attend the 24th Scientists Forum.The forum, themed "Promoting International Scientific and Technological Exchange and Cooperation, and Advancing Collaborative Innovation among Industry, Academia, Research, and Application," brought together experts and scholars in science and technology, representatives of research institutions, and leaders of innovative enterprises. Discussions focused on technological innovation, achievement commercialization, international cooperation, and industrial collaboration.
As part of the forum, a special roadshow on technological innovation and project applications provided a platform for presenting scientific and technological achievements and exploring their industrial applications.During the event, Huangfulijun introduced the company's patented bonding process for medical endoscope light-guide fibers and its project for the localization of core components for rigid endoscopes. He presented the technological value of the innovation in improving fiber-bonding quality, enhancing component reliability, and facilitating domestic applications.
From patent development to industrial application, and from independent innovation to industry collaboration, Jiacheng Medical remains committed to addressing practical application needs and promoting closer integration between R&D achievements and medical device manufacturing.
IV. Scientific Exchange: Advancing Industry-Academia Collaboration
On December 12, 2024, Huangfulijun, founder of Jiacheng Medical, returned to Beijing to attend the 9th Enterprise Chief Scientist Forum, the launch ceremony of the Enterprise Chief Scientist Hundred-Person Initiative, and an international cooperation and exchange symposium featuring Nobel Laureate Professor Thomas C. Südhof.
The event focused on cultivating new quality productive forces, independent innovation, research integrity, and strengthening international scientific and technological cooperation. Internationally renowned scientists, industry leaders, and experts in science and technology innovation gathered to discuss new opportunities for technological innovation and high-quality industrial development.
During the event, Huangfulijun engaged in discussions with Professor Thomas C. Südhof, recipient of the 2013 Nobel Prize in Physiology or Medicine, as well as industry experts and representatives of relevant think tanks. Discussions covered technological innovation, the commercialization of research achievements, and enterprise innovation and development. He also participated in relevant think-tank exchange activities associated with the Enterprise Chief Scientist Hundred-Person Initiative.
For enterprises specializing in the R&D and manufacturing of precision optical components for rigid endoscopes, technological innovation requires not only sustained investment in research and development but also close engagement with cutting-edge technologies, research resources, and practical application needs.Through participation in high-level scientific and technological exchange events, Jiacheng Medical continues to strengthen communication with the scientific and industrial communities while actively exploring effective approaches to technological innovation and industrialization of critical components.
V. Independent Innovation: Supporting Domestic Development
From independent development of core manufacturing processes to industry recognition of patented achievements, and from participation in high-level scientific forums to the exploration of industry-academia collaboration, Jiacheng Medical has consistently regarded technological innovation as a key driver of development.The company remains focused on precision optical core components for rigid endoscopes, continuously strengthening its independent R&D and precision manufacturing capabilities.
Looking ahead, Zhejiang Jiacheng Medical Instrument Co., Ltd. will continue to address key technological requirements in rigid endoscope core components, combining independent R&D with manufacturing process innovation. The company will further advance the transformation and industrial application of patented technologies, while continuously improving product reliability, operational stability, and manufacturing standards.Through sustained innovation and specialized manufacturing, Jiacheng Medical is committed to contributing to the localization and development of critical components for high-end medical devices.
Seeking collaboration? [Contact us →]
Attachment:Patent Certificate for High-Temperature Resistant Adhesive
